Medulloblastoma in young adults. Must we give adjuvant chemotherapy?
Medulloblastoma is a rare entity in adult patients. All data about treatment are from children, where this disease is the most common cerebral tumour. Reports of medulloblastoma in adults are scarce but in all of them the prognosis seems similar to the prognosis of children. We present our experienc...
Gespeichert in:
| Veröffentlicht in: | Clinical & translational oncology 2007-02, Vol.9 (2), p.121-123 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 123 |
|---|---|
| container_issue | 2 |
| container_start_page | 121 |
| container_title | Clinical & translational oncology |
| container_volume | 9 |
| creator | Roussos, I Balaña, C Cuadras, P Ballester, R Etxaniz, O Hostalot, C |
| description | Medulloblastoma is a rare entity in adult patients. All data about treatment are from children, where this disease is the most common cerebral tumour. Reports of medulloblastoma in adults are scarce but in all of them the prognosis seems similar to the prognosis of children. We present our experience in five cases of medulloblastoma in young adults, treated at the University Hospital "Germans Trias i Pujol" from June 1994 to October 2003. This has not been a good experience as more than 50% of the patients had a recurrence in spite of the standard treatment. We have reviewed the literature, concluding that we have to adapt the findings in children to our adult patients, offering them adjuvant chemotherapy after surgery. |
| doi_str_mv | 10.1007/s12094-007-0024-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70216178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70216178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c299t-1e35f14c19033608c744aa35022e81b0b1861830972070175ccaaf2fcf6c78c93</originalsourceid><addsrcrecordid>eNpFkEtPwzAQhC0EoqXwA7ggn7il7NqJHZ8QanlJrbiAxM1yXKdNlUeJk6L-e1w1EofVjkYzc_gIuUWYIoB88MhAxVGQ4VgcJWdkjEKpiEOSnA8a4vR7RK6830JwBeIlGaHkTDEmxmS-dKu-LJusNL5rKkOLmh6avl5TE_zOT-my9x39dXRd7F0wt_3e1B21G1c13ca1Znd4vCYXuSm9uxn-hHy9PH_O3qLFx-v77GkRWaZUF6HjSY6xRQWcC0itjGNjeAKMuRQzyDAVmHJQkoEElIm1xuQst7mwMrWKT8j9aXfXNj-9852uCm9dWZraNb3XEhgKlGkI4ilo28b71uV61xaVaQ8aQR_R6RM6fZRHdDoJnbthvM8qt_pvDKz4HxxPaJw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70216178</pqid></control><display><type>article</type><title>Medulloblastoma in young adults. Must we give adjuvant chemotherapy?</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Roussos, I ; Balaña, C ; Cuadras, P ; Ballester, R ; Etxaniz, O ; Hostalot, C</creator><creatorcontrib>Roussos, I ; Balaña, C ; Cuadras, P ; Ballester, R ; Etxaniz, O ; Hostalot, C</creatorcontrib><description>Medulloblastoma is a rare entity in adult patients. All data about treatment are from children, where this disease is the most common cerebral tumour. Reports of medulloblastoma in adults are scarce but in all of them the prognosis seems similar to the prognosis of children. We present our experience in five cases of medulloblastoma in young adults, treated at the University Hospital "Germans Trias i Pujol" from June 1994 to October 2003. This has not been a good experience as more than 50% of the patients had a recurrence in spite of the standard treatment. We have reviewed the literature, concluding that we have to adapt the findings in children to our adult patients, offering them adjuvant chemotherapy after surgery.</description><identifier>ISSN: 1699-048X</identifier><identifier>EISSN: 1699-3055</identifier><identifier>DOI: 10.1007/s12094-007-0024-5</identifier><identifier>PMID: 17329226</identifier><language>eng</language><publisher>Italy</publisher><subject>Adult ; Cerebellar Neoplasms - drug therapy ; Cerebellar Neoplasms - surgery ; Chemotherapy, Adjuvant ; Female ; Humans ; Male ; Medulloblastoma - drug therapy ; Medulloblastoma - surgery</subject><ispartof>Clinical & translational oncology, 2007-02, Vol.9 (2), p.121-123</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c299t-1e35f14c19033608c744aa35022e81b0b1861830972070175ccaaf2fcf6c78c93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17329226$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roussos, I</creatorcontrib><creatorcontrib>Balaña, C</creatorcontrib><creatorcontrib>Cuadras, P</creatorcontrib><creatorcontrib>Ballester, R</creatorcontrib><creatorcontrib>Etxaniz, O</creatorcontrib><creatorcontrib>Hostalot, C</creatorcontrib><title>Medulloblastoma in young adults. Must we give adjuvant chemotherapy?</title><title>Clinical & translational oncology</title><addtitle>Clin Transl Oncol</addtitle><description>Medulloblastoma is a rare entity in adult patients. All data about treatment are from children, where this disease is the most common cerebral tumour. Reports of medulloblastoma in adults are scarce but in all of them the prognosis seems similar to the prognosis of children. We present our experience in five cases of medulloblastoma in young adults, treated at the University Hospital "Germans Trias i Pujol" from June 1994 to October 2003. This has not been a good experience as more than 50% of the patients had a recurrence in spite of the standard treatment. We have reviewed the literature, concluding that we have to adapt the findings in children to our adult patients, offering them adjuvant chemotherapy after surgery.</description><subject>Adult</subject><subject>Cerebellar Neoplasms - drug therapy</subject><subject>Cerebellar Neoplasms - surgery</subject><subject>Chemotherapy, Adjuvant</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medulloblastoma - drug therapy</subject><subject>Medulloblastoma - surgery</subject><issn>1699-048X</issn><issn>1699-3055</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtPwzAQhC0EoqXwA7ggn7il7NqJHZ8QanlJrbiAxM1yXKdNlUeJk6L-e1w1EofVjkYzc_gIuUWYIoB88MhAxVGQ4VgcJWdkjEKpiEOSnA8a4vR7RK6830JwBeIlGaHkTDEmxmS-dKu-LJusNL5rKkOLmh6avl5TE_zOT-my9x39dXRd7F0wt_3e1B21G1c13ca1Znd4vCYXuSm9uxn-hHy9PH_O3qLFx-v77GkRWaZUF6HjSY6xRQWcC0itjGNjeAKMuRQzyDAVmHJQkoEElIm1xuQst7mwMrWKT8j9aXfXNj-9852uCm9dWZraNb3XEhgKlGkI4ilo28b71uV61xaVaQ8aQR_R6RM6fZRHdDoJnbthvM8qt_pvDKz4HxxPaJw</recordid><startdate>20070201</startdate><enddate>20070201</enddate><creator>Roussos, I</creator><creator>Balaña, C</creator><creator>Cuadras, P</creator><creator>Ballester, R</creator><creator>Etxaniz, O</creator><creator>Hostalot, C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070201</creationdate><title>Medulloblastoma in young adults. Must we give adjuvant chemotherapy?</title><author>Roussos, I ; Balaña, C ; Cuadras, P ; Ballester, R ; Etxaniz, O ; Hostalot, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c299t-1e35f14c19033608c744aa35022e81b0b1861830972070175ccaaf2fcf6c78c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Cerebellar Neoplasms - drug therapy</topic><topic>Cerebellar Neoplasms - surgery</topic><topic>Chemotherapy, Adjuvant</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medulloblastoma - drug therapy</topic><topic>Medulloblastoma - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roussos, I</creatorcontrib><creatorcontrib>Balaña, C</creatorcontrib><creatorcontrib>Cuadras, P</creatorcontrib><creatorcontrib>Ballester, R</creatorcontrib><creatorcontrib>Etxaniz, O</creatorcontrib><creatorcontrib>Hostalot, C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical & translational oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roussos, I</au><au>Balaña, C</au><au>Cuadras, P</au><au>Ballester, R</au><au>Etxaniz, O</au><au>Hostalot, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medulloblastoma in young adults. Must we give adjuvant chemotherapy?</atitle><jtitle>Clinical & translational oncology</jtitle><addtitle>Clin Transl Oncol</addtitle><date>2007-02-01</date><risdate>2007</risdate><volume>9</volume><issue>2</issue><spage>121</spage><epage>123</epage><pages>121-123</pages><issn>1699-048X</issn><eissn>1699-3055</eissn><abstract>Medulloblastoma is a rare entity in adult patients. All data about treatment are from children, where this disease is the most common cerebral tumour. Reports of medulloblastoma in adults are scarce but in all of them the prognosis seems similar to the prognosis of children. We present our experience in five cases of medulloblastoma in young adults, treated at the University Hospital "Germans Trias i Pujol" from June 1994 to October 2003. This has not been a good experience as more than 50% of the patients had a recurrence in spite of the standard treatment. We have reviewed the literature, concluding that we have to adapt the findings in children to our adult patients, offering them adjuvant chemotherapy after surgery.</abstract><cop>Italy</cop><pmid>17329226</pmid><doi>10.1007/s12094-007-0024-5</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1699-048X |
| ispartof | Clinical & translational oncology, 2007-02, Vol.9 (2), p.121-123 |
| issn | 1699-048X 1699-3055 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70216178 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Adult Cerebellar Neoplasms - drug therapy Cerebellar Neoplasms - surgery Chemotherapy, Adjuvant Female Humans Male Medulloblastoma - drug therapy Medulloblastoma - surgery |
| title | Medulloblastoma in young adults. Must we give adjuvant chemotherapy? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A30%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medulloblastoma%20in%20young%20adults.%20Must%20we%20give%20adjuvant%20chemotherapy?&rft.jtitle=Clinical%20&%20translational%20oncology&rft.au=Roussos,%20I&rft.date=2007-02-01&rft.volume=9&rft.issue=2&rft.spage=121&rft.epage=123&rft.pages=121-123&rft.issn=1699-048X&rft.eissn=1699-3055&rft_id=info:doi/10.1007/s12094-007-0024-5&rft_dat=%3Cproquest_cross%3E70216178%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70216178&rft_id=info:pmid/17329226&rfr_iscdi=true |